Clinical study on the treatment of chronic obstructive pulmonary disease group D in stable stage with integrated traditional Chinese and Western Medicine

Phase 1

Completed

• Conditions: chronic obstructive pulmonary disease

• Registration Number: ITMCTR2100004968
• Lead Sponsor: Hospital of Chengdu University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 50-75 years;
2. Meet the diagnostic criteria for stable chronic obstructive pulmonary disease in Western medicine;
3. Meet the diagnostic criteria of TCM syndrome of yang deficiency and blood stasis and phlegm turbidity in the lung;
4. Acute exacerbation >= 2 times or >= 1 time leading to hospitalization in 1 year;
5. mMRC grade >= 2;
6. Exclude other lung diseases and lung diseases caused by other systemic diseases;
7. Agree to participate in clinical observation and be able to receive treatment and various examinations, and sign the informed consent.

Exclusion Criteria

1. Asymptomatic or only pulmonary function test FEV1/FVC<0.70;
2. Suffering from severe cardiovascular disease, central nervous system disease, liver and kidney insufficiency, history of gastrointestinal bleeding, severe diabetes, malignant tumor and other diseases;
3. Patients with anxiety, depression and other mental illnesses;
4. Allergic constitution and allergic to the test drug;
5. Those who cannot take the medicine on time and are not expected to complete the 6-month treatment and follow-up;
6. Patients who are participating in other clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TCM syndrome quantification integral;